SUBSCRIBE: Print / Digital / eNewsletter
In the decades that Dermatology Times reporters have covered the specialty, we’ve had the pleasure of profiling the specialty’s champions. Some shared their professional accomplishments, while others revealed unknown aspects of their personal lives. Here just some of the interesting tidbits from years’ past.
Allan C. Halpern, M.D., discusses what dermatologists need to understand about AI and how it might interact with or disrupt the specialty.
Suneel Chilukuri, M.D., weighs in on what physicians need to know about microneedling, including plusses and minuses of devices on the market, FDA clearance, ideal candidates, how to incorporate microneedling into treatment regimens and how to avoid complications and potential liability.
While laser ablation tops foam sclerotherapy in five-year QOL and cost-effectiveness outcomes, researchers believe foam is an evolving treatment option for varicose veins.
Studies support using microneedling as monotherapy to treat acne scars; however, mixed evidence requires more direct comparisons with other minimally invasive treatments.
A 40mg doxycycline dose with a topical containing adapalene 0.3% and benzoyl peroxide 2.5% is an effective and safe treatment option for severe acne, according to a single-center pilot study published recently.
Children with atopic dermatitis — especially moderate-to-severe disease — seem to have an risk of developing other atopic diseases, such as asthma, allergic rhinitis and food allergies, says this expert.
An expert speaks with Dermatology Times about the nuances of diagnosing, treating and managing eczema in black patients.
Matthew J. Zirwas, M.D., presented a comprehensive primer on the drug types at the October Maui Derm NP + PA Fall 2019 meeting in Asheville, N.C. Read his insights in this article.
Suneel Chilukuri, M.D. presented on the science of neuromodulators at the October Maui Derm NP + PA Fall 2019 meeting in Asheville, N.C. Read insights gleaned from his presentation in this article.
We've noticed that you're using an ad blocker
Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.
